Article
A novel multiplex polymerase chain reaction assay for detection of both HLA-A*31:01/HLA-B*15:02 alleles, which confer susceptibility to carbamazepine-induced severe cutaneous adverse reactions.
HLA - 1 Dec 2017
Nguyen D V, Vidal C, Chi H C, Do N T Q, Fulton R, Li J, Fernando S L
Abstract excerpt
HLA-A*31:01 and HLA-B*15:02 have been widely reported to confer genetic susceptibility to carbamazepine (CBZ)-induced severe cutaneous adverse reactions (SCARs). Accordingly, the screening for these alleles has been highly recommended to prevent SCAR prior to introducing CBZ therapy. Although a number of methods are available for screening of HLA-A*31:01 or HLA-B*15:02 alleles separately, developing an assay that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.